Business Description
JD Health International Inc
ISIN : KYG5074A1004
Compare
Compare
Traded in other countries / regions
06618.Hong Kong8ZN.GermanyJDHIY.USA IPO Date
2020-12-14Description
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2023, the platform has over 180 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 220.11 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-EBITDA | 0.07 | |||||
| Interest Coverage | 84.51 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.34 | |||||
| Beneish M-Score | -2.1 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 21.2 | |||||
| 3-Year FCF Growth Rate | -7.2 | |||||
| 3-Year Book Growth Rate | 5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 30.93 | |||||
| Future 3-5Y Total Revenue Growth Rate | 10.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.97 | |||||
| 9-Day RSI | 49.97 | |||||
| 14-Day RSI | 50.14 | |||||
| 6-1 Month Momentum % | 9.38 | |||||
| 12-1 Month Momentum % | -24.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.74 | |||||
| Quick Ratio | 3.35 | |||||
| Cash Ratio | 3.26 | |||||
| Days Inventory | 45.74 | |||||
| Days Sales Outstanding | 2.32 | |||||
| Days Payable | 83.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.01 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 22.57 | |||||
| Operating Margin % | 1.41 | |||||
| Net Margin % | 4.76 | |||||
| FCF Margin % | 11.74 | |||||
| ROE % | 5.19 | |||||
| ROA % | 4.04 | |||||
| ROIC % | 4.65 | |||||
| ROC (Joel Greenblatt) % | 442.11 | |||||
| ROCE % | 6.53 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 29.24 | |||||
| Forward PE Ratio | 16.75 | |||||
| PE Ratio without NRI | 29.3 | |||||
| Price-to-Owner-Earnings | 29.5 | |||||
| PS Ratio | 1.41 | |||||
| PB Ratio | 1.51 | |||||
| Price-to-Tangible-Book | 1.61 | |||||
| Price-to-Free-Cash-Flow | 12.01 | |||||
| Price-to-Operating-Cash-Flow | 11.93 | |||||
| EV-to-EBIT | 10.53 | |||||
| EV-to-Forward-EBIT | 12.66 | |||||
| EV-to-EBITDA | 10.53 | |||||
| EV-to-Forward-EBITDA | 11.72 | |||||
| EV-to-Revenue | 0.63 | |||||
| EV-to-Forward-Revenue | 0.49 | |||||
| EV-to-FCF | 4.84 | |||||
| Price-to-Graham-Number | 1.46 | |||||
| Price-to-Net-Current-Asset-Value | 2.02 | |||||
| Price-to-Net-Cash | 2.46 | |||||
| Earnings Yield (Greenblatt) % | 9.5 | |||||
| FCF Yield % | 7.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
JD Health International Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 7,022.595 | ||
| EPS (TTM) (€) | 0.107 | ||
| Beta | 0.82 | ||
| Volatility % | 73.55 | ||
| 14-Day RSI | 50.14 | ||
| 14-Day ATR (€) | 0.093687 | ||
| 20-Day SMA (€) | 3.338 | ||
| 12-1 Month Momentum % | -24.41 | ||
| 52-Week Range (€) | 2.28 - 4.531 | ||
| Shares Outstanding (Mil) | 3,198.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
JD Health International Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
JD Health International Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
JD Health International Inc Frequently Asked Questions
What is JD Health International Inc(FRA:8ZN)'s stock price today?
The current price of FRA:8ZN is €3.34. The 52 week high of FRA:8ZN is €4.53 and 52 week low is €2.28.
When is next earnings date of JD Health International Inc(FRA:8ZN)?
The next earnings date of JD Health International Inc(FRA:8ZN) is 2025-02-15 Est..
Does JD Health International Inc(FRA:8ZN) pay dividends? If so, how much?
JD Health International Inc(FRA:8ZN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers